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ABSTRACT 
An a ste rosaponin extracted £rom. the Atlantic starfish _A. ste r~~ 
forbesi (Desor) has teen evaluated for pharmacological activity. 
The investigation has revealed that while the asterosaponin does 
not exi1ibit all the activities that would be expected, such as herno-
toxicity to blood cells, choline rgic blocking activity, initiation 0£ 
a.voidance .i.'ebEJOnse reaction or production of autotomy, it does ex-
hibit soLJ.e unique propert: ,o: s not demonstrated by other a sterosap-
onins. These activities include an z. lgesia, anti-inflarnrna tion, a.nd 
transient hypotension produced by a direct effect on the vascular 
bed. 
The bovine serum albumin assa.y Jor anti-in£lamrnatory activity 
showed that a concentration of 500 µg/rnl of asterosaponin caused 
an 85% inhibition 0£ protein denaturation. The rat paw edema assay 
demonstrated that pretreatment with asterosaponin at 75 mg/kg ip 
significantiy reJuced the edema caused by the ca rrageenin injection. 
In both cases the response was dose dependent. 
The analgesic activity of the asterosaponj.n was analyzed using 
the Koster acetic acid writhing test. Significant analgesia was dem-
onstrated with a dose of asterosapcrnin 2.s low as 15 mg/kg while 
25 mg/kg was capable of r educing the writhes by 99%. 
i 
The transient hypotensive activity of the asterosaponin was 
demonstrated in rats, cats, and dogs. Utilizing the cat it was dem-
onstrated that very low doses of the asterosaponin (0. 5 mg/kg) could 
significantly transiently lower the blood pressure, but had no effect 
on the nictitating membrane or on somatic muscle contraction. 
The rat was less sensitive to the intravenously administered astero-
saponin then Lhe cat, eliciting a hypote nsive effect only when concen-
trations oi 4 . 0 rng/kg or higher were administered. The sensitivity 
of the d og to asterosaponin was intermedia t e . The dog exhibi.te d 
a drop in blood pr essure when a dose of 2. 0 mg/kg of asterosaponin 
was adn1inistered, and similar to the cat and rat showed a dose 
response relation ship ~o the asteros aponin. 
The rnechanisrn by which the asterosaponin caused the transient 
d1·op in blood pressure was investigated by an analysis of vagal 
influence, the possibility of histamine release, direct action on the 
vasculature and th e possible complex involvement of some type 
of adrenergic blockade or stimulation using an experimental set up 
rnonitoring blood pressure, heart rate and ECG. The data showed 
that th e asterosaponin continued to exhibit its hypotens ive ac tion 
even when the vagus nerves were severed, the animai was pretreat-
ed with antihistarnine, the a lpha recepto rs were blocked, or when 
the b eta receptors wer e bi.ocked. 
l l 
The hind leg perfusion experim.ent perfonned on the rat proved 
that the asterosaponin was acting directly on the vasculature. The 
experiment showed that the asterosaponin was capable of causing 
vasodilation directly when all neural influences were removed by 
cervical dislocation and severing, and was even capable of acting 
in the presence of beta blockade created by the administration of 
propranolol to levels which blocked isoproterenol effects. 
111 
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I. INTRODUCTION 
The phannacological evaluation of compoun ds extracted from 
plant or animal sources is basic to the science of pharmacology. 
The employment of animals and plants from the marine environment 
as a. soucce for biologically active compounds has created the field 
of n.1.arine ph2.rrnacology. 
The isolation of toxic saponin cornpounds from starfish in the 
ea.rly 1960s (Hashimoto and Yasumoto, 1960) renewe d the scien tifi c 
argument as to whether starfish e1nploy some type of toxin in order 
to facilitate prey procurement, specifically the opening of the bi-
valve shell. Further res e arch into the phannacological properties 
of these asterosaponin corn.pounds (Rio et al., 1963; Yasurnoto -~! 
7 
al., 1964; Rio et al., 1965; Yasurnoto et al., 1966; Friess~ al., 
1968; Friess, 1970; Shimizu, 1971, 1972) indicated that the asterosap-
onins were not a toxin used by the starfish to aid in the opening of 
bivalves but that these and related ccrnpounds did possess many 
pharmacological properties. These properties included activity as 
antiviral agents (Shimizu, 1971), anticoagulant a.gents (Baslow, 1969), 
cytotoxins (Ruggier i, 1965), reducers of sperm motility (Ruggi er i, 
1965), choline rgic blocking agents (F' rie ss, 1970), hemotoxic agents 
8 
(Owellen et al., 1973), producers of an avoidance response reaction 
by mollusks (Mackie et al. , 1968) and antifungal agents (Wolters, 1968). 
Dr. Yuzuru Shimizu isolated an antiviral asterosaponin extract 
fro1n the .A.tlantic starfish Asterias forbesi in 1971. This astero-
saponin (Figure 1) is an aglycone with a sulfate group and sugars 
attached , That structure is characteristic of saponin cornpounds 
derived from starfish and is very similar to compounds extracted 
from I-Iolothurins (Friess et al., 1965; Friess and Durant, 1965). 
The investigation of the pharmacological properties of this purified 
and identified asterosaponin from ~-ster~as £9rbesi was the basis 
for this thesis. The investigation was aimed at evaluating the astero-
saponin for pharn1acological activities that had be e n exhibited by 
other asterosaponin or related compounds. The investigatorfl were 
a l so interested in evaluating the extract for properties not previously 
associated with a&terosaponins and to determine the mechanism 
by which these activities we re produced in the hope that the compound 
rnight exhibit activities that would be cf use as either a research 
tool or a possible drug. 
0 
SULFATE 
FIGUR E 1. STRUCTURE O F AS T EROSAPON IN 
FROM ASTERIAS FOR BESI 
0 (SUGARS) 
n 
FU COSE 
QUINOVOSE 
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II. LITERATURE REVIEW 
Nigrelli (1952) isolate d the first saponin of animal origin when 
he isolated the compound he later called Lolothurin from a sea 
cucumber. The Holothurian from which the saponin was isolated 
is a rnernb e r of Lhe phylum Echinodermata as are the Asteroidea 
or star.fish. Hu!othurin was shown to exhibit toxic effects on th e 
killiii sh c:,nd pea. rl fish, and the compound restricted the growth of 
10 
sarcoma 180 in Swiss Webster mice. I'·Jigrelli ~al. (1955) reported 
on the che1nical nature of this compound from the Holothur i an and 
showed that this toxic compound had a steroid nucleus and a r:r1ono-
sacchar ide moiety. Sullivan et~· (1955) demonstrated that the 
compound had anti-tumor activity on the Kr eb s - 2 Ascites Tumors 
in Swiss mice. The investigation of the pharma cologic properties 
of this toxin was c o ntinued w ith the work of F1:iess et al. (1959) 
who demonstrated that the tox in had irreversible blocking effects 
on the rat phrenic Eerve-diaphrarn preparation. 
w·ork cmcerning holothurin cmtinued into the 1960 s v.1 hen Frie SS 
and Durant (1965) and Frie ss~ al. (1965) demonstrated that the anti -
cholin ergic activity of t h e toxin demonstrated through the rat phreni c 
nerve experiments cculd be partially blocked by physostigmine and 
neostigmine. 
11 
Saponins from other animals were discovered in the early 1960s 
when Matsuno and Yamanouchi (1961) isolated a saponin from a dif-
ferent Holothurian then the one Nigrell:i had used. This was done 
while the choline rgic involvement of toxic substances fron1 echino -
derms beca1ne even more well docu1nented through the work of Mendes 
et ~l. (1963). 
The isolation of toxic principles from the Echinodern1ata re-
kindled the long fought argument over the possible presence of some 
type of toxic substance in starfish which is used by the starfish to 
facilitate food procure1nent, specifically a toxin that would reduce 
the effort necessary for the sta.rfish to open the bivalve shdl. 
The toxic substance investigated by this research was isolated 
from the Atlantic starfish Asterias forbesi and was tested on one of 
the starfish's comrnon food sources, the quahog Mercenaria rnercen-
aria. Thus the literature dealing with possible toxins possessed by 
starfish has focused on this particular starfish, ancl when possible 
in relation to the clam Mercenaria mercenaria. 
The first hint of evidence for or against a toxin being used by 
the starfish Asteri;:is fo r besi con1es fro:m the work •:)f Galtsoff and 
Loosanoff (1939). · While inv estigating the problcrr; of Asterias 
forbesi plundering the oyster a.nd clam beds of the eastern shore 
they observed that, on occasion, specimens of Aste rias would be 
12 
unable to open large r.ciollusks and would leave the mollusk and go on . 
The conclusion could be made that if a toxin were present in the 
starfish, it would be unlikely for this response to be necessary. 
Further evidence against the presence of a toxic substance used by 
Asterias forbesi in food procurement has been presented by the 
work of Burnett (19 55, 1960). Burnett showed that for Asteria s 
J.?._E.~~esi the:ce have been no evolutionary pressures to develop such 
a toxin beca1:Lsr~ '.:he starfish is .fully capable of exerting a force grea.t-
er than 5, 500 grams, a full l, 000 grams greater then the force 
needed to open a quahog. Burnett demonstrated that the sta dish 
does not pull on the shell of the quahog continuously and that the shell 
halves w ill frequently snap shut on the everted stomach, with no 
noticable adverse eHects to the starfish. Furthermore, Burnett 
(1960) showed, using Aste.E_~as forbesi and Mercenaria mercenaria 
that the ston1ach of the starfish could pass through very small open-
ings in the clan1 and that th0. starfish contained stomach enzymes 
capable of digesting the living clam. Burnett concluded (1960) that 
t!Thus, there is strong e vidence that Asterias secretes no poison 
before it begins to digest a clam. 111 
1 A. Burnett, 11 The rnechanisrn ernployed by the starfish Asterjas 
forbesi to gain access to the interior of the bivalve, Venus mercenaria, 11 
Eculogy ±l_ (1960): 584 . 
13 
Lavoie (1956) presented additional evidence that starfish e1nploy 
no toxic compound in their acquisition of food by using extracts of 
Asterias i_orbesi on the rn.ussel Mytilus edulis. Various extracts 
from the stornach and pyloric caeca were tested by a nw:nbe.r of tech-
niques. The extracts were tested by injection into the rnantle cavity 
of the mussel, by injection into the adductor rnuscles, by addition 
to the sea water containing tile mussel and the extract was even 
per£uf>ed on the expo sed heart of the Mytilus. All of the experiments · 
·with all the extracts produced the san1e results; there was no differ-
ence in the effect seen with the starfish extract from the response 
seen with sea water used as a control. Lavoie aiso de1nonstrated 
that the starfish could enter the clam through a gap as small as 
0. 1 nun. However, the conclusion that was made by Lavoie was that, 
'
1The negative results of the experin1ents involv ing sea star extracts 
are not proof that asteroids do not secrete a toxin during predation, 
but they do indicate that no such substance can be separated from the 
sea star organs by the extraction methods used. 112 The conclusion 
indicates the dilemma these investigators face. It is irnpossible 
to prove that a toxin does not exist, and only possible to prove that 
one does exist when it is derr10nstrated un e quivocally. This has 
not be en done. 
2," L _ . , 1i:..:r 
lvl.. . a-vo1e, Low sea ::;tars open bivalve s , 11 Biol. Bull. 111 
(195 6 ): 122 . 
14 
Christensen (1957) also supported the mechanical theory of 
starfish access to mollusks, that is, that force was the 11 primary11 
method employed by seastars of the Asterias type to gain access to 
the tis sue of the bivalve prey. The hesitance on the pa rt of the 
researcher to completely dispel the idea of a toxin being present 
is evidenced here by the choice of the word 11 primary11 • 
Nichols (1964) continues to include the idea that a toxic sub-
stance is b eing used by starfish in prey predation, anC. Aldrich pre-
sents observational data (Aldrich, 1954 ) in his Ph.D. dissertat .ion 
that extracts from Aste rias fo r~e si_ do indeed produce relaxation 
of the adductor muscles r;f ]yiytilus edulis and 11odiolus demissus 
plicata. Aldrich 1 s data however i_s based on observations of the 
response of Mod_i.olus demissus to extracts of Asterias tissue where 
a gaping response was interpreted as being the result of a toxic 
substanc e present in extracts from. pyloric divertic;ilun-i. Unfor-
tun.ately no reason was given by Aldrich as to why the response 
of Modiolus was inconsistant. With both the filtered and dialized 
extracts there appears to have been specimens which were not af-
fected by the extract. Observations of an Asterias feeding on a 
Mytilus edulis is the second source for Aldrich 1 s belief that the 
starfish contains a toxin. The fact that the starfish stomach is evert-· 
ed at the begining of the attack supposedly suggests the role of a 
15 
chemical rnediator prior to the mechanical phase of penetration. 
Hashimoto and Yasumoto (1960) in studying an extract from the 
starfish Asterjna pectinifera which had been shown to b e toxic to 
oyster hearts, could hinder the ecdysis of fly maggots, and was 
toxic to fish and warm blooded animals, noticed that the water in the 
aquarium which held the starfish often turned foamy when starfish 
died. I--lypotbes.izing that the extract that they had been studying might 
be respcnsihJe for this foaming, and knowing that one of the prop-
erties of saponins is their surfactant nature, they initiated a search 
for a saponin compound in the starfish. Inde ed , when isolation 
procedures were completed the compound was classifie d as a saponin. 
Continuing their work Yasurnoto a nd Hashimoto, together with 
Watanabe (Yasumoto et al., 1964) s h owe d that w ith better extraction 
procedures u sing the starfish Asterias amurensis a highly purified 
toxic saponin fraction could be obta ined. This new asterosaponin 
proved to be hemolytic to rabbit blood and toxic to killifish, earth-
worms and fly maggots. When 80 rng of the starfish saponin was 
injected into the mantle cavity of three individual oysters through 
a hole in the edge of their shells, these shell fish, which were kept 
in an aquarium, showed no signs of relaxation of the adductor muscles 
for the six hour observation time. 
These resul ts of Yasumoto ~__! ~· (1964) sugges t that the aste ro-
saponin is not 1 esponsible .for facilitating the starfish 1 s ability to 
16 
open the clam or oyster, but that it may be present for another 
purpose as y e t obscure. This corresponds with the opinion of F e der 
and Christensen (1966) who believe that there is no basis for the 
toxin theory. Howe'7er they do believe toxic substances a re pr e s e nt 
in starfish, but that they are not utilized for prey procurement. 
Yasumoto ~ ~· (1966) investigated whether starfish in general 
possess saponins since saponins had b een believed to be r est ricted 
to the plant kiDg dom prior to the work of Nigrelli. Analyzing five 
different starfish species , they found that all the s tarfish analyzed 
did contain saponins. The saponins we re found in a ll parts of the 
starfish body and were at highes t concentrations in the summer 
rnonths. 
Rio et a l. (1 963) in Nigrelli 1s laboratory detennined tha.t th e 
giant sunburst starfish Pycnopodia helianthoides from the Pacific 
n orth west also pos se ss ed a saponin, and tha t t his asterosaponin 
differed from the Holothurian saponin. The compo und was cytotox ic 
and h emolytic and contained a steroida l aglycone characteristic 
of the s a ponins. 
A toxic extra ct from Asterias £orbesi was demonstrated by 
Chaet in 1962. He showed that the scalded coeleo1nic fluid of Astei- i as 
contained a toxin which when injected into the peritoneal cavity of the 
s tarfis h Asterias £or1~~si ca'...ised autoto1ny (the rejection of the star-
fish1s own arms) 2.nd death. Toxic fractions from other species 
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of Asteria s we re examined by Fange (1963) who showed that an 
extract from Asterias _E21bens produced the irreversible contraction 
o.f the isolated Buccinum radula muscle. This fraction was inactiv-
ated by b o iling . 
Rio et al. (1965) evaluated the biological activities of extracts 
from five starfish species . Althoug h one of the asterosaponins eva l-
uated was extracted from Aste rias forbesi, it is not believed that 
- -
the c ornponnd is t he same as the compound isolated by Shimizu. 
No structure for the compound was determined, but the extraction 
procedures are n ot the same. The Aste rias for be si toxin was shown 
to be toxic t o Fundulus heteroclitus down to a level of 2 pg/ml. 
However, no marke d eosrnophil.ia or hernolytic activity was reported 
for the compound. The compo1-md was shown to imrnoboli z e sperm 
and cytolyz e unfertilized sea urchins eggs. 
Friess, Durant and Chanley (1968) used i.he rat phrenic nerve-
diaphram preparation on two saponins from the starfish Asterias 
amurensis to evaluate the cholinergic properties of the asterosaponins 
as they had done for the holothurin in 1959. Their work established 
that these two saponins demonstrated irreversible blockade of con-
tractural responses elicite d b oth directly and indirectly. 
In 1970 Friess reviewed the literature o n the steroidal sapon in 
esters £::om Echinoderms (Friess , 1970 ). The c ompounds investigated 
were ±:rom s ea cucumbers and starfish and all contained the steroidal 
18 
nucleus, polysaccharide moiety and esterified sulfuric acid residue, 
w hile some of the sugars present on the moiety included D-quinovose 
and D-fucose. Refering to the work 0£ Hashimoto on Asterias am -
ure ~sis Friess pointed o ut that both asterosaponins A and B extracted 
from the starfish contained the same aglycon es and one sulfate group . 
The sulfate group was suggested to be the part of th e compound 
re sponsible fur tD.e toxicity and anionic character. Compound A 
co'1.tained only tl~e terminally reduced sugars fucose and quinovose 
but both asterosaponin A and B were 11 quite'' powerful in destruction 
of excitability of a cholinergic neuromuscular preparation. 
Shimizu in 1971 iso l ated an anti-viral substance from the star-
fish Asterias forbesi (Shimizu, 1971) . This compound later (Shimizu, 
1972) was established to be of the class.ical steroidal aglycone, poly-
sac cha ride moiety and sulfate derivative form, and is the compound 
that was used in this investigation. 
Mention has already been made to the possibility of an avoidance 
respons e reaction being caused by the asterosaponin. The work of 
Fange (19 63 ) Feder and L asker (1964) Feder and Arvidsson (1967) 
and Mackie et al. (1968) clearly shows that extracts from starfi sh 
could initiate an escape response in rnollusks . The observations 
of Pratt and Campbell (195 6 ) suggested that the mollusk Me rcenaria 
mercenaria n1ay be able to sense the presence of Asterias forbesi 
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and initiate an avoidance or escape response. These beliefs were 
based on the observation that quahogs appear to burrow deeper when 
Asterias are in the vicinity of the bivalves. 
Aste rias forbesi often feeds on 1.:he clan1 Mercenaria mercenaria. 
There is evidence that asterosaponins can be cardioactive (Hashimoto 
and Yasumoto, 1960) and this is another side to the debate as to 
.,,-_,he~.he;_· the sta riis h opens the bivalve with shear force or through 
ihe use of a toxie. In order to facilitate an evaluation of the bivalve 
toxicity, and the cardioactive and cholinergic properties of the astero-
saponin b ackgrcund information on the anatomy and physiology of 
!~e!cenaria rne rc 811~ria , its heart, and the chemicals it is sensjtive 
to was necessary. This information has be en given by Prosser 
(1940), Gre enberg and J ega l (1963), Greenberg (1965), Florey (1967) 
and Agar wa l and Greenberg (1969). 
Advancing the research covered by this thesis into activities 
of asterosaponins not already cited as being properties of astero-
saponins it was decided to investigate the possibility of anti-inflam-· 
lnatory activity, analgesic activity, and the effects of the astero-
saponin on the rnammalian cardiovascular systern. Reviewing the 
literature on anti-inflammatory assay procedures it was determined 
to us e the procedures of Grant ~J. al. (1970) fo.:.· the in vitro assay 
and that of Winter et a l. (1963) and Winter anc~ Flataker (19 65 ) for 
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the in vivo method. The procedure of Koster~ al. (1959) was 
reviewed and chosen to be used to evaluate the analgesic activity 
of the asterosaponin. 
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III. EXPERIMENTAL 
A. Animals 
Male albino rats we i ghing between 150 to 500 grams and male 
mice, 30 to 50 grams (Charles River Breeding Labor atories, Wil-
m.ingto11, 1v1ass3chuestts) were used. The animals were housed 
10 quar tel"s JY1aintained at 21-23°C with room lights on alternating 
12 hour ligh t-dark cycles. Corn.rnercial laboratory chow and water 
were allowed ad libitum. Anirnals we.::e used no earli er than three 
days foUow5ng receipt frorn the supplier. 
Cats and dogs from. the University of Rhode Island College of 
Pharmacy 1 s kennel were of mixed breed. 
Clams, Mer~~_?aria mercenaria, were obtained from Wickford 
Shell Fish Inc. (Wickford , Rhode Island). The clams were stored 
in aerated artificial sea water aquaria (Aquarium Systems, Inc., 
Cleveland, Ohio). The temperature of the sea water was rnaintained 
at 15-20°C with room lights on alternating 12 hour light-dark cycles" 
The starfish (Asterias forbesi) that were us ed for the extraction 
procedure and for experimentation were collected from Narragansett 
Bay in the shallow areas (usually at low tide) off the rocks close 
to Hazzard Ave. in Narragansett, Rhode Island . 
The snail Littor~E_~ _!_itt o r ea was collected on the rocky shore 
2, 2 
of Narragansett Bay at low tide near the ''Towers" of Narragansett, 
R.hode Island. 
B. Materials 
Analytical grade chemicals or equivalent were used throughout 
the study. Carrageenin was obtained from Marine Colloids, (Rock-
land, Maine). 
Two sc.n:pJ.i:, 5 of asterosaponin were used in this investigation. 
The origi1ia1. extract , produced by Dr. Yuzuru Shimizu of the Depart-
ment of Pharmacognosy of the University of R.hode Island was only 
occasionaly used in the investigation as indicated. The major por-
ti.on of the research was carried ou_t on ::Da.teri2.l that was extracted 
and purified by Les Goldsrnith durin g the Sl.L.'"Y1mer of 1973 under the 
guidance of Dr. Yuzuru Shimizu. 
C. Analytical Procedur e s 
The asterosaponin was dissolved in 0. 9% saline for intravenous 
and intraperitoneal administration, artificial sea water for marine 
preparations, distilled water for in vitro preparations and Ringer-
Locke solut:i on for hind l eg perfusion preparations. The asterosaponin 
was often used in doses of l. 5 x 10-powerg/ml because the estimated 
molecular weight of the compound was l, 500 (Shimizu, 1972) thus 
allowing for easy conversion to rnolar concentration. 
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1. Cholinergic Assay and the Effects of Asterosaponin on the Mer-
cenaria mercenaria Heart 
Large bivalves 1'.1ercenaria rn.ercen2.ria were kept in aerated 
artificial sea "''ater 15-20°C until u.scd. The dissection was carried 
out under sea water. A bivalve specimen was selected ci.nd the edge 
of the shell taped until a small crack appeared. The clam was then 
opened by cutting the adductor inuscles, and care was taken not to 
injure the portic)n of the clam close to the hinge, as this was the 
vicinity of the heart. After removal of extraneous tis sue, the dorsal 
half of the clam_ was transfered into the dissection dish with the 
dorsal side (containing the heart) up and a superficial sagital cut 
was made along the dorsal body wall. The heart was then isolated 
and prepared for removal by cutting the intestine which passed through 
the heart on both sides. Ligatures were tied around both ends of the 
ventricle, so that eventually one could be attached to a transducer 
and the other to a glass hook. The heart was severed distal to both 
ligatures and immediately transfered to a 10 ml muscle bath with a 
surrounding jacket through which cooled (18°C) wate1· was purnped 
to regulate the temperatur e of the heart and solutions. A constant 
but gentle stream of air bubbles continualJ.y oxygenated the bea rt 
preparation. The heart was held in the bath with one ligature connect-
ed to a glass hook at the botton~ of the bath while the other ligature 
was connected to the A-715 transducer attached to a Physiograph 
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(E. M. Instrument Co., Houston, Texas). 
Standard dilutions were nl.ade of acetylcholine in sea water 
-4 -12 
to cover a range of 1. 0 x 10 g/ml to 1. 0 x 10 g/ml. One ml was 
added to 9 ml of sea \vater to reduce the concentration by 1 power 
of 10. The effect of the acetylcholine, or test drug was recorded 
for 30 seconds and then the heart was flushed two times with sea 
water and a il o'>ve d to stabilize for o ne rninute or longer. Starting 
·' with the l. 0 x 10 -- 12 g/ml concentration of acetylcholine, the concen-
tration was increased until the h ea rt beat stopped. ·Interme diate 
concentrations between the level of acetylcholine that conl.pletely 
stopped t:b.e contractions and the next more dilute concentration 
we1·e occasionally appli ed to exceptionally sensitive hearts to attain 
a finer comparison of activity. 
The acetylcholine effect was then compared to the effect of 
different concentrations of the asterosaponin, following the same 
procedure. Sarnple s of acetylcholine, giving known activity were 
administered intermittently to the test preparation during astero-
saponin testing to rnonitor the deterioration of the sensitivity of the 
preparation. The anticholinesterase neostigmine and the antichol-
inergic atropine were used to gain more info rmation £ro1n the prep-
aration. 
2. Effect of Asterosaponin on the 'Whol e Clam Mercenariamercenaria 
Five lar ge bivalves 1v1ercenaria mercenaria had s1nall holes 
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drilled in the ventral lateral section of their shell so that a small 
syringe needle could be inserted into the mantle cavity of the clam. 
Four of the clams were injected with l rnl of 1. 5 x l0- 4 g/rn_l astero-
saponin while the fifth received a 1 rnl injection of sea water. The 
c lams were all placed in a container of aerated sea water for 24 
hours and observed for any type of reaction to the experimental 
pl'ocedure . 
Expe rim en ts designed after the experiments of Mackie et al. 
(1968), were performed to determine if there were any escape re-
sponse reactions 0£ the local salt water species of gastropod, _Lit-
torina littorea to the asterosaponin. 
The snails were placed in individual beakers of sea water that 
were positioned over pieces of graph paper. When nonna1 explor-
atory activity of the snail had resurned, the asterosaponin was gently 
injected into th e sea water close to the head of the snail with a syringe. 
T h e response of the snail was then recorded, using the graph paper 
squares to dete rmine the movement of the snail. Injections of sea 
water via syringe into the snail 1 s sea water environment at the pr ox--
in1ity of his head were used as a control. A different snail was used 
for each dose of asterosaponin tested. 
The following procedure \Vas used to determine if the Asterias 
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forbesi asterosaponin exhibited blood cell lysing properties similar 
to other asterosaponins. Rat blood obtained from tail veins was 
treated with concentrations of asterosaponin ranging from 0. 3 to 
10. 0 mg/nil, or witli the st3.ndard lvierck saponin used for blood 
count deterrni:;.1ations. The bloo<l san1ples were placed in a Coulter 
Counter and the blood count determined. 
Chact in i9(;2 had dernonstrated the ability of a co1npound from 
the sea lded coe lornic fluid of Asteria s forbesi to bring forth an au ton-
oewus loss of arms by that starfish, when the coin pound was injected 
into its peritoneal cavity. The procedure used in this res~arch to 
investigate this property being possessed by the asterosaponin from 
Asterias forb e si was similar. 
----- ·- - ---
Intermediate sized starfish 8-12 crn in diarneter were injected 
intraperitoneally with 1 ml of l. 5 x 10- 4 g/ml asterosaponin and then 
placed in the aqua·riurn for observation. Control starfish received 
intraperitoneal injections of l ml of seav,1ater . The starfish were 
observed for .four hours and a bno nnal reactions were recorded. 
The starfish were then observed periodically for the nex t twenty 
hours. 
6. Analg esia 
The rnethod of Koster (1959) was the method used to evaluate 
the analgesic properties of the &sterosaponi;-i. Groups of 5 mice 
were pretreated by ip injection with either; l) saline (0. 1 ml/g) 
2) morphine (10 mg/kg) or 3) asterosaponin. The asterosaponin 
was dissolved in saline and was adrninis terpd at 6 dosage levels 
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ranging from 10 mg/kg to 50 mg/kg . Fifteen minutes after the pre-
treatment :injections the mice received ip injections of 0. 01 ml/g 
of 0. 6% fresh acetic aci d . Three minutes after the acetic acid injec-
tions the w ri thes exhibited by the group of mice were counted and 
to~aled fo _r twelve minutes. In this procedure reduction in w rithes 
is equated with analgesia. 
7. _In Vitro Anti-inflammatory As~ 
To evaluate possible anti-inflarnmatory activity by the a ste ro-
<::aponin the in vitro assay of Grant~ al. (1970) was e1nployed. 
The assay en1ploys the use of bovine serum albumin. Many corn -
poun ds that prevent inflarnmation also are capable of reducing ti1e 
heat denaturation of a l.bumin protein. 
Th e test system contained 2 rr1l of 1% bovine serurn albumin and 
2 ml of 0. 05 M Tris acetate buffer, pH 6. 0 or test solution in 2. 
te st tube. Cont ro l and test systems were heated in a constci.nt temper-
atur e bath using the Haake FK2 ccnstant tem.perature circulator 
at 69. 5°C for exactly four rninutes. The test tubes we re th en placed 
in ic e and their turbidities were read <'.t 660 mr1 on a Beckman model 
DB-G spectrophotometer. If the original turbidity was above scale, 
the sam.ple was dilluted 9: 1 with distill~d water. The value of the 
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percent of control turbidity was calculated and an analysis of var-
iance calculated to determine if ther was a significant drug effect . 
8 . In Vivo Anti-in£laE1'1-mato ry As sa_y 
Since positive results obtained from _?-_r: vitro anti-infiammato ry 
assays are inconclusive in deterrr1ining the presence of anti-inflam-
matory activity for a compound, the in vivo anti-inflammatory pro-
cedure of Winter et al. {1963) was also ernployed. Rats weighing 
approxi:nate ly E;o g received either no pre-t .reatxnent, asterosaponin 
75 mg/kg ip or phenylbr:.tazor:>e 90 mg/kg ip, one hour p~·ior tn ec.leCJ.1<: 
productic 1 . :=:dema was produced by the inj<~cti.or: of 0. 05 ml of 1% 
c:a:crageenin into the sub-plan"Ler tissuE' of a hix::6 pa -;;,· of a r at . Th<~ 
vo lurne of the paw was then innnecli.ately deterrni:--ied by the use of 
a prcviousiy calibrated volume dii:~pla cern_e nt apparatus which employ-
ed the use of a 50 ml syringe iilled with mercury corn:!ecte;d th rough 
a p l astic catb. ·.~ter tc. a :St2.Lharr-1 P ;~3 transducer iinked to a Grass 
The tcxi.ci ty oi !:he asten:' sa:pc~1_i_J:l was evaluated in mice. Groups 
of 5 rna.le mice -~'/ e:re i:;jccted i r:d:r<.1.peritcnc:ally w.ith 5-0 , 100, 2.00, 
or 400 r_ng/kg oi L:ic: :J.sterosaponin. 
The respo~1s::: of tbe mic:e to tlu· int raper itoneal asteroaaponin 
injection \'vas obse r ved for t wo h ou.1·s aod ~:hen intermittant obser-
vatir__:.ns we ·e m<.;.;c; c·ver the ne>..t thn~e d'1y::>. Thi= number of deaths 
were recorded and an LD50 estimated from the results. 
10. Cat Blood Pres sure and Nervous System Evaluation 
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The effect of the asterosaponin on blL)Od pressure, respiration, 
the autonon1ic nervous systen1, and skeletal in us cle re spans e to 
neuronal. stin1ulation were determined using a cat. 
A cat was anesthetized wi.th pentobarbital. The cat's respiration 
'Nas mon[tored by the use of a sensitive thermocouple inserted into 
the plabtic cannula used in the tracheoton1y. The thermocoupl e 
was then connected to the Grass polygraph via a Grass model 7PlB 
low level D. C. pre-amplifier aD.d a model 7DAE Grass polygraph 
D. C. driver amplifier. Blood pressure was monitored using the 
cannula.tion of the femoral artery connected to the same Gr.ass poly-
graph and amplifier system by a 1nodel P 23 De 10 volt Statham 
transduc er . The effect of stimulating the nictitating membrane 
was also recorded on the polygraph. The nictita ting men1brane 
response was tested via supramaximal stirr1ulation (7 volts, 5 per 
second for 2. 0 milliseconds) of the cut preganglionic cervical syrn-
pathetic nerve . The response of a striated rnuscle (tibial.is anterior) 
to supramaximal stimulation (10 volts, 1 per second for 2. 0 inil-
lis econds) of the p e riph e ral end of the cut peroneal nerve was also 
monitored. The tibialis anterior and the nictitating membrane were 
connected to a Grass force displa c emen t transducer model ~T 03C 
connected to the polygra ph to r ecord contractions of the muscle 
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or membrane. 
The effects of the asterosaponin on the monitored parameters 
were eval uated after intravenous administration of the canpound. 
Vfhenever the asterosaponin or other drug was administered the can-
nula was immediately flushed with saline. 
/ 
11. Blood Pressure and ECG Resoo nses of the Rat to Asterosaoonin 
------------· ---
The response of the cat to asterosaponin adrninistration initiated 
interest into the cardiovascular effec t s of the asterosaponin. These 
cardiovascular effects of intravenous asterosaponin achninistration 
were further investigated primarily in the rat. 
A rat was anestheti7-ed with ur ethane (6 rn.l/kg of 20% solution, 
i p). A tracheal cannula (a 1. 5 11 piece of PE tubing , size 280 or 
smaller) was then inserted and tied securely. The femoral vein, 
as it passed into the iliac vein was exposed and cannulated with PE 
10 tubing and connected to a l ml syringe that was filled with saline. 
This cannula was used for intravenous drug ad1ninistration. Each 
of the con1mon carotids were exposed and separated from the surround-
ing tissues . Then the two nerves, the vagus and the cervical syrn -
pathetic which lie along the carotids, were carefully and gently 
separated from the section of the vesse l to be us ed for blood pressure 
catherterization usin g PE 90 tubing. Prior to its insertion the cannula 
was attached to the saline filled transducer system in the 1.isual . 
rn.anner and the tip filled with heparin solution. A blood pr e ssure 
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bottle filled with 250 ml of saline and 2. 5 ml of heparin (1000 units /ml) 
had been previously attached to this transducer. This system was 
used to re co rd the blood pressure changes following drug adminis -
tration . 
To record the rat 1 s ECG three needle electrodes were placed 
subcutaneously. The ground electrode was connected to the leg of 
th1:: rat that v: 2, s not used for the intra7enous catheterization. The 
two ren1a i njng electrodes were placed on the .chest of the rat or 
on his outstreached forepaws. The electl"odes were connected to the 
Grass polygraph wide band A. C. pre-amplifier and integrator model 
7 P3A which was connected to the Grass polygraph D. C. Driver 
arnplifier inodel 7 Di',E . The paper speed was kept at 2. 5 mm/sec. 
except for recording at critical times at 100 inm/second. 
12. Dog Blood Pressure, Heart Hate, and ECG in Response to 
Asteros a ponin 
T he experimental set up to monitor the effects of the astero-
sapo.nin on the blood pressure, heart rate, and ECG of the dog was 
sirnilar to that of the rat. The dog was anesthetized with pentobarb-
ital 30 mg/kg and a tracheotomy performed. The f e moral vein was 
cannulated on one leg of the dog for the ad1ninistration of drug i'1tra-
venously. The femoral artery on the other l eg was cannulc<.ted and 
attacheci to a pr essure transducer for the r eco rding of the arterial 
blood pressure through a Grass polygraph. The ECG recording 
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responses to the vagus. 
In a s e cond part 0£ the experiment, asterosaponin was adn1in-
istered after the vagus nerves had been severed, and the results 
recorded to compare them to the normal effects of the asterosaponin 
or; a rat with intact vagus nerves. 
14. Evaluation of the Histamine ReleasiE_g Potential of A sterosaponin 
The prJssibility that the hypotensive effect seen with the astero-
sapo nin adrnini8 tration could be caused by endogenous histamine re-
lease was evaluated. Rats were prepared for ECG monitoring and 
blood pres s ure determination. The antihistamine diphenhydran1ine 
w.a s adrninistered intravenous ly to the r a t until su££icient amounts 
were present to prevent the hypotensive activity of intravenously 
adrninistered histamine (0. 5 mg/kg). When a protective level of 
antihistamine was attained asterosaponin (15 mg/kg) was administered 
intravenously to d eterrr1ine ii the hypotensive action of the astero-
saponin could be blocked by pretreatment with the antihistamine. 
15 . Evaluatio n of the Alpha Adrenergic Blocking Capabilities of 
}\ ste ros_aponin 
An analysis of the in£luence of the asterosaponin on the alpha 
receptors of the adrenergi.c nervous system was possibl e from the 
cat nictitating membrane exp e riment. To gain more direct evidence 
for the possibility of this type of activity, a specific experirnent was 
designed, incorpor2.ting the rat blood pr e ssure preparation . 
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Rats were prepared for the usual ECG and blood pressure 
d eterminations. Phenoxybenzamine was then administered to the 
rat to the point where no further drop in blood pressure was seen. 
Then asterosaponin (15 rng/kg) was adrninistered intravenously to 
deterrnine if the asterosaponin could produce further hypotension 
even though the alpha receptors we re blocked. The normal proce -
<lure of flushing each dose of a.dministe red drug with saline before 
the next drug was administered was maintained and ample tirne 
was a.llowed for each drug to have an effect. 
16. Evaluation of Beta S!imulating Properties of .Asterosaponin 
The stirnulation of the vascular beta receptors by adrenergic 
agonists can significantly alter peripheral resistance. The stimu -
lation of these beta receptors leads to a drop in blood prei;)sure 
through vasodilation. The determination of the possibility of as-
terosaponin acting as a peripheral vascular beta stimulant was car-
ried out using the rat blood pressure technique. The possibility 
of b eta influence was also invest i gated with the rat hind leg perfus-
ion experiment (see below). 
A rat was pre pared for blood p ressure and heart rat e rnonitoring 
following the standard procedure for the blood pressure and ECG 
determi.'1.ation. The beta. blocking agent propranolol was a.dminister--
ed intravenously to the rat a.t very high doses (O. 9 rng /kg), so that 
no stimulation o f the beta receptors was possible. After this blocking 
dose had been administered, asterosaponin was injected and the 
blood pressure measured to determine if the asterosaponin (15 
mg/kg) could produce hypotension even though the beta receptors 
were blocked. 
17. Evaluation of Asterosaponi~orking Directly on the Vascula-
!ur~.I.~_e Rat Hind L~ Perfusion Procedure 
The results of the previous experirr1ents aimed at detenn]ning 
the site of aste:rosaponin action in connection with the production 
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0£ transient hypotension made it necessary to further evaluate the 
possibility that the asterosaponin was acting directly on the vascula-
ture . The perfused hind limb preparation makes this type of eval -
uation possible. 
A rat was anesthetized and attached to a rat board that was 
mounted on approximately a 50° angle so that the scrotal sac of the 
rat was positioned at the lower end of the board. The abdorninal 
cavity was opened and the skin pulled away from the musculature 
surrounding the scrotal sac and along one leg. The vena cava and 
decending aorta were carefully isolated below the level 0£ the kidney 
and anterior to where they bifurcate into the lower appendage s. 
The vena cava was tied just below the level of the kidney and the 
aorta was cannulated. The cannu la to the aorta was attached to 
a three way stopcock permitting aerated body temperature Ringer-
Lockc solution t o be p erfused at a constant pressure into the artery. 
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The stopcock could also be turned to allow for the administration 
of drugs via a syringe. The veins of the le g that had the skin pulled 
away were severed so that the perfnsate could travel through the 
arterioles and vascular bed and ernerge through these severed veins. 
A small hole was plac ed at the bottom 0£ the scrotal sac and an eye 
dropper inserted therein so that the perfusate from the leg would 
pass through t he eyedropper, dropping through a drop counter 
connected to the polygraph. Since the pressure was constant, 
changes in the diameter of the vessels in the leg were reflected 
in the num.ber of drops during a prescribed period of time. 
Through the three way stopcock epinephrine (4. 0 pg) and iso-
proterenol (0. 1 mg) were administered to establish the reliability 
of the preparation. Standard amounts of Ringer-Locke solution 
were also administered to evaluate the effect of the injection process 
itself on the preparation. Asterosaponin was administered to record 
its effects on vascular resistance. Then the combination of adren-
ergic blocking and sti1nulating agents was used as a pretreatment 
before the asterosaponin to verify the hypothesized rnechanism of 
action of the asterosaponin. 
D. Statistical Methods 
The 2-tailed Student's 11 t 11 test for ind e pendent means was used 
to exa1nine experirnental ineans for statistical significance. The 
level of significance (P) was detcrrnined b y comparison of the 
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computed 11 t 11 value with values from standard tables. All calculat -
ed 11 t 11 values were tested at the 0. 05 level for rejection of the null 
hypothesis. In sorne instances an analysis of variance, F test for 
experimental means was used to examine experimental means for 
statistical significance. The level of significance (P) was determined 
by comparison of the computed F value with value s from standard 
tables. All calculated F values were tested at the 0. 05 level for 
rejection of the null hypothesis. 
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IV. RESULTS 
A . Me rcena ria. mercenaria Heart Evaluation for Choline rgic A cti-
vity by Asterosaponin 
The clam_ heart bioassay established no activity by the astero-
saponin for the dose range of 1. 5 x lo- 18g/ml (1. 0 x io-18M) to 1. 5 
7 -7 
x 11)- g/ml (l. 0 x 10 M) (Table 1). The injection procedure, the 
f reshness of the toxin, freshness of the preparation, and the order 
of the administration of the drug had nc; effect on the results . This 
was den1onstra.ted in several ·ways. The injection of artificial sea 
water into the b a thing mediun1 producing no adverse effects showing 
the injection procedure itself did not affect the contractions of the 
isolated heart. The order in which the different concentrations 
of the drug were administered likewise did not alter the results 
attained. In some instances the lowest concentrations of asterosap-
onin were administered first, working progressively toward higher 
concentrations. On other occasions the experiment was initiated 
using the middle concentration and at times using the highest concen -
tration of drug. The possibility that the process of acetylcholine 
ad1ninistration prior to asterosaponin preve nted the effects of the 
asterosaponin was not seen. Table l shmvs that the .!:"eliability of 
the preparation was checked on every occasion for sensitivity to 
TABLE l. THE EFFECT OF ASTEROSAPONJN & ACETYLCHOLINE ON THE 
CONTRACTIONS OF THE ISOLATED HEART OF M.E.RCEN.AIUA MERCENARIA ____ ........
Acetylcholine concentrations lOpowe r g /ml ~ · t +-" @ 1 5 lOpower / 1 1 ox1n cone en ra~wns . x g m 
Power"" N ...... 0 co r- '-D L!) ~: (¥") N ...... 0 CJ' 00 r-
...... ...... ...... ...... 0' co r-
'° 
L!) 
...... 
, ..... ...... ...... ~· ...... ,....; ...... ...... 
I I I I I I I I I I ! I I I 
' 
I I I I I 
1 y -·-;.,------··----:-::-a: x x 'T z z x x y°" x y x ... 
2 x x x y z x x 0 y x x x 
3 y x z x x y x yb 
4 x y y z x x x Xe 
!1 x x x y z x x 
6 x y z x x x 
d 
7 x y y z z 
e 
8 x y z x x x 
9 z z x x x 
lOf z z x x 
0 = paired contraction effect . The amplitude of the first contraction is smaller then the amplitude of 
the second, then the pattern repeats 
X = no effect; Y = slight drq::i in amplitude same frequency; Z = severe drop in amplitude & frequency 
-..!) 
I 
x 
x 
x 
w 
·.o 
EXPLANATION OF TABLE 1 
a This recording was r ecorde d as a slight drop. However this was 
probably due to the instability of the preparation since after sea 
water replacen1ent the contractions were larg e r then with the toxin 
for the first 3. 5 minutes but then the amplitude of the beat was com-· 
parable to that exhibited with the toxin. 
b -7 The dose of 1. 5 x 10 g/ml was r e peated later in the expedment, 
after trials with both toxin and acetylcholine, with the same effect. 
c The 1. 5 x 10- 7 g/ml dose of toxin by itself had no effect, and with 
' 
neostigmine (0. 25 mg) pretreatment it continued to show no effect. 
d Atropine was used to assure that the preparation was responding 
correctly. -6 When atropine was pr esent at 1. 0 x 10 M the heart stop-
ped contracting. 
e . -7 . h Atropine pres ent at 1. 0 x 10 M prutected against t e effect of 
-8 -8 1. 0 x 10 g/ml (5. 5 x 10 M) acetylcholine. 
f 
Toxin given before acetylcho1.ine 
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acetylcholine, and on numerous occasions checked with atropine as 
an anticholinergic drug. The data rn Table 1 show that the hearts 
-9 
were all sensitive to acetylchol.ine at the concentration of 1. 0 x 10 
g/ml (5. 5 x l0- 9M) and rnany of the hearts were sensitive to concen-
-13 -13 
trations as low as 1. 0 x 10 g/ml (5. 5 x 10 M). Table 1 contains 
-7 data that also show that when atropine was present at l. 0 x 10 M 
it protected the preparation against the effect of l. 0 x l0- 8g/ml 
( 5 r: 1 ., - 8 . -) t l b i · • :J .x .v Lvi ac e y c .o ine. At doses of the asterosaponin ranging 
-18 - 7 from 1. 5 x JO g/ml to 1. 5 x 10 g/ml there was no effect produc ed 
on the heart. The adrninistration of neostigmine (0. 25 mg) to the 
test preparat.i.on did not alter the lack of effect on the preparation 
produced by l. 5 x 10- 7 g/ml of asterosaponin. 
B. Effect of Asterosaponin on the Whole Clam Mer~e~·ia_mer -
cena ria 
Neither the asterosaponin injec tion nor the sea water injection 
into the intact clan1 caused any abnormal reactio n by the cla:;:n. 
-4 Clams that were injected with 1. 0 ml of 1. 5 x 10 g / ml of astero-
saponin did n ot appear to differ in any way fro1n the clan1 receiving 
l. 0 ml of sea water. 
Since many asterosaponins reviewed in the literature and sap -
onins in general exh ibjt hemolytic a ctivity it was detern.l.ined that 
it \.Vould be nEcessary to evaluate this ::i.sterosaponin for l:ernolytic 
41 
activity. Table 2 shows that the astero saponin possessed no cytotoxic 
activity towards rat l e ukocytes or erythrocytes at doses ranging 
up to 10 mg/ml. 
D. A::itotorn.end Asterosaponin 
Since another investigator (Cha et 1962) had sho wn that an extract 
from Asterias forbesi was c apabl e of inducing autotorny in Aste~ias 
i£!be~i_, the asterosaponin was evaluated for autotor.-iy activity to 
deterrnine if it was the active constituent. The data (Table 3) denl.-
onstrate that the aste rosaponin from Asterias forb c s_~ \.v as incap-
able of causing autotomy in the starfish Asterias f'.~ . .:-:2~?.si. 
The ability of thf:: asterosaponin to initiate an avoidance response 
in Littorina littorea wa s evaluated (T a ble 4). The results demon-
-5 
strate that wh::;n 1. 5 x 10 g of asterosaponin was i nje c ted into the 
water near the snails head no abnormal behavior was generated and 
no avoidance r e sponse observed. 
F . Anti - inflammatory Activ ity 
Becaus e of the know n anti--inflammatory activity of a wide var1-
ety of steroids the steroidal asterosaponin was tested for anti-infla1n-
mator y activity with two djfferent tests, the in vitE_£ bovine serum 
albumin denaturati::rn as say and the in vivo carrageenin induced 
rat bind paw edema a ssay. 
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TABLE 2. EVALU.A.TION OF BLOOD CELL LYSING 
PROPE RTIES OF ASTEROSAPONIN 
Treatment Concentration a Cytotoxic Activity 
RBC WBC 
··----
_Asterosaponin 10 no no 
Asierosapon in 5 no no 
, 
Asterosaponin 2. 5 no no 
Asterosaponin 1. 2 no no 
Asterosaponin 0.6 no no 
Asterosaponin 0. 3 no no 
Merck Saponin yes yes 
a mg/ml of whole rat bloo d 
~ ·. 
TABLE 3. AUTOTOMY BY ASTERIAS FORBESI IN RESPONSE 
TO ASTEROSAPONIN INJECTION 
T reatmenta Nb C oncentration 
Asterosaponin 6 1. 5 x 10- 4g/ml 
Sea vVate r 2 100% 
-----·--·---
a 1. 0 ml inj ection into the peritoneal cavity 
b Number of starfish 
c 
Starfish were observed for 24 hours 
Autotomy c 
no 
no 
43 
TABLE 4. AVOIDANCE RESPONSE INITIATION 
PROPERTIES OF ASTEROSAPONIN IN LITTORINA LITTOREA 
a 
44 
T reatrnent Nb Conc entration Esca2e ResEonse 
Asterosaponin 10 .1. 5 x l0- 5g/ml no 
Sea '1'late r 3 100% no 
a 
1. 0 nl.l inj er:tion in irnmediate vicinity of the snails 
b Number of animals 
45 
The bovine serum album.in assay for anti-inflammatory activity 
showed (Table 5) that a concentration of 500pg/ml of asterosaponin 
caused an 85% inhibition of protein dena tu ration. Phenylbutazone, 
the well known anti-inflarnrna.tory agent, restricted the denatura-
t:ion by over 80% at a co:c.centration of l2Cpg/rnL Vvhen the data 
was plotted (Figure 2) both the aste rosaponin and phenylhutazone 
produced this restriction of c!enaturation in a log dose response rnan-
.w2r-. Since the asterosap•Jnin ::-esuits were posib?c for this test 
which is used to screen new drugs for anti-inflar:nmato ry activity, 
the in viv~ carrageenin induced rat paw ederna as8ay was chosen 
to deterrnine if the asteros2.;::;onin ·,;vas capable of r-=stricting in£lam-
n:cation in the intact aniinaL 
The rat paw edema assay (Table 6) showed that pretreatment 
with asterosaponin at 75 ing/kg ip reduced the ederna caused by the 
carrageenin i1--;jection by 53 percent. Pretreatrr1en t v; ith pbenylbut-
azone (90 mg/kg) had a sirnilar effect, decreasing inflarr1mation 
by 52 p ercent. 
The evaluation of the LD50 of any toxic co.r:npound is pararno 1:rnt 
to any type of drug tes t ing procedure. The d2. t ~, of the LD ,- l.-, dete rm-
:::i J 
ination (Table 7) for the asterosaponin dern.onstrate that the aste.::-o-
saponin has a .LDr ,-, v::t lne ln mice between 100 and !.'.CO mg/kg . 
.Ju ..... 
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TABLE 5. ANTI-INFLAMMATORY ACTIVITY OF 
ASTEROSAPONIN AND PHENYLBUTAZONE THROUGH 
THE BOVINE SERUM ALBUMIN ASSAY SYSTEM 
a T reatrnent 
Percent of 
Control Absorbancec 
Aste ros a ponind 
30 
60 
120 
250 
500 
1000 
Phenylbutazoned 
30 
60 
120 
250 
500 
1000 
a 
,ug /ml 
b Nurnbe r of replicates 
c 660 nm 
2 
2 
4 
2 
2 
2 
2 
2 
4 
2 
2 
2 
70. 34 ± 3.07 
63. 63 ± 0. 00 
+ 55.06 - 2.84 
28. 46 ± 4. 83 
+ 14. 31 - 3. 41 
ll.92-!:0.79 
53. 58 "±: 4. 22 
+ 43. 32 - 2. 23 
+ 17.49 - 2.56 
+ 0. 90 - 0.90 
0. 90 ± 0. 90 
+ 0. 90 - 0. 90 
d Significant drug effect P<O. 05 (Analysis o.f Va riance ) 
w (.) 
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FIGURE 2 . INHIBITION OF BOVINE SE RUM AL B UMIN 
DE NA TURA TION BY AS T E ROSAPONIN A ND 
P H E NYLBUTA ZONE 
* ASTEROSAPONIN 
-e- PHENYLBUTAZONE 
o' I I I 13! ' ' 
.02 .04 .06 0.1 0.2 
AMOUNT OF DRUG 
0.5 
(mg/ml) 
1.0 
..i:. 
-J 
TABLE 6. RAT PAW EDEMA 
a b Vohunec 
Treatm_ent N 0 hr ~.J::E.__ ____ (3 hr)-(0 hr) 
Control 
Asterosaponin 
(75 mg/kg) 
Phenylbutazone 
(90 mg/kg) 
a 
4 
4 
4 
1401. 1 ~ 103. 8 + 2201. 2 - 143. 9 
14 (. ~ I + 28 5 oti. o - • + 1846. 3 - 70. 2 
1476. 0 ~ 72. l 1860. 4 ~ 88. 3 
Injection (ip) of test compound one hour prior to injection of 0. 05 ml of 1% 
car rageenin i'.1to tre sub planter tis sue of the hind paw 
b 
Number of rats 
C ., r , 3 
Vornrne or paw u1 mm 
d 
Significantly lli.flerent from control, P<O. 05 
+ 800. 1 - 61. 5 
377. 7 ~ 81. 5d 
384.3~47.8d 
>i'-
00 
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TABLE 7. LD50 IN MICE FOR ASTEROSAPONIN 
Treatment Dos ea Nb 
Aste rosaponin 400 5/5 
Asterosaponin 200 5/5 
Asterosapon i n 100 5/0 
Aste :ros;:iponin 50 5/0 
a 
mg/kg, ip 
b 
Numb e r of rn.ice injected/numb e r <lead w ithin 48 hours 
H. Analgesic Activity 
In a further evaluation of pharrnacological activity, the anal-
gesic activity of the asterosaponin was evaluated, employing the 
Koster acetic acid assay (Koster, 1959). The asterosaponin was 
effective in reducing the writhes exhibited by mice due bJ acetic 
50 
acid injection (Table 8) and therefore extremely effective as an anal-
gesic agent. VVi'..ile the 10 and 12 mg/kg doses did not reflect anal-
ger::ic activity, the 15 mg /kg dose did reduce the writhes exhibited 
by the group by 71 percent. Higher doses possessed even greater 
analgesic activity as 25 mg/kg reduced thew rithes by 99 percent 
and 50 mg/kg reduced w:rithes by 100 p e rcent. These results of 
asterosaponin incho_c.ed analgesia wel·e compared to the results ob -
tained with morphine which at 10 mg/kg reduced writhes by 100 
percent. 
I. Cat Blood Pressure and Nervous Syste m 
The effects of aste ro saponin injected intravenously at diffe cent 
dosages upon a number of physiological processes we re monitored 
in the cat. The effects of the toxin on blood pressure, respiration , 
prega nglionic sympathetic nerve stimulation, and stimulation of 
a sornatic motor nerve to a striated muscle were all recorded . 
Figure 3 shows the polygraph recordings that we r e taken of 
a cat prior to any drug administration. The chart shows an initial 
blood pressure of 100 mm Hg, ll, 5 breaths per minute, and the 
51 
TABLE 8. MOUSE ANALGESIA AS EVALUATED FROM 
WRITHES FOLLOWING ACETIC ACID INJECTIONS 
Percent of 
a 
Trialsb Writhesc Pretreatrnen t Dose Control 
-· 
S.::.line 0. 9% O.Olrn.1/g 4 146 
1vfo rphine 10 mg/kg 2 0 0 
Aste rosaponin 10 mg/kg l 143 98 
Aste ro saponin 12 mg/kg l 139 95 
Asterosaponin 15 mg/kg 1 43 29 
Asterosaponin 20 mg/kg 1 11 7 
Asterosaponin 25 mg/kg 1 2 1 
Asterosaponin 50 mg/kg 1 0 0 
a 
ip injections 15 minutes prior to treatment with 0. 01 rng/g of 
0. 6% acetic acid 
b 
Number of times that dose of compound was tested 
c I\1ean nurnber of writhes exhibited by the group of 5 mice during 
the 12 minute p eriod star.ting 3 rninute s aiter acetic acid injection 
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striated muscle contracting normally to stimulation. The cont rac-
tion of the nictitating membrane is not shown but the membrane was 
contracting normally in response to nerve stimulation. 
Figure 4 is a recording rnade after the intravenous injection 
of l. 0 mg/kg of asterosaponin . The blood pressure of the cat re-
mained at the pretreatment level of 100 mm Hg for 9 seconds and 
then began to decline. The lowest ievel of 50 mm Hg was reached 
17 seconds after the injection. The blood pressure returned to a 
level of between 95 and 100 mm Hg 44 seconds after the injection. 
The respiration, skeletal muscle contractions and nictitating mem-
brane all functione d normally during the time that the drug was 
active on the blood pres sure. 
Figure 5 illustrates the e ffect of the injection of 2. 0 mg/kg 
of asterosaponin on the monitored physiological functions of the 
anesthetized cat. The:re was the usual delay of onset of the action 
of the asterosaponin, in this case 11 seconds, before there was a 
drop in blood pressure. The pressure reached its lowest level of 
50 mm Hg 20 seconds after the injection, a drop of 42 mm Hg from 
pre-drug level of 82 mm Hg. The blood pressure did not return to 
near normal l eve l for 126 seconds. The nictitating membrane func-
tioned normally to the stimulus, but the contraction 0£ the skeletal 
muscle, appeared to b e sligh'~ly decreased in arr1plitude . The res-
piration was increas8d by this dose of ast:erosaponin< The original 
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respiratory rate was 11. 5 breaths per minute. After the aste ro-
saponin the rate increased to 16 breaths per minute for approxim-
ately one minute then dropped to 15 per minute. Nine minutes af-
ter asterosaponin injection resp.i.ration was still at an elevated level 
0£ 14 breaths per minute although at this time the a ste ro sapo nin 
had ceased to have an effect on the blood pressure. 
The data for the response of the cat1 s physiological para1neters 
' for all of the do se s of asterosaponin adrninistered are compiled in 
Table 9. These data clearly show that the asterosaponin from As--
!erias forbesi was capable of dose dependently causing a transient 
lowering of the blood pressure o f the anesthetized cat. These data 
also show that the asterosaponin had no eifect on autonomic ganglia 
as the response 0£ the feline nictitating membrane was not altered 
throughout the dose range administered when the preparation was 
stimulated preganglionically. The asterosaponin did not appreciably 
affect the functioning of the somatic peroneal nerve or the function-
ing of the skeletal muscle. 
J. Rat Blood Pressure , Heart Rate and ECG Response to Astero-
saponii: 
Figure 6 shows the norn1al recording for blood pres sure and th 
normal ECG pattern of a typical .rat before any drug vva.s injected. 
The blood pressure was 75 mm Hg, there were 270 heart beats 
per miP..ute and the ECG was r egular. A control determination was 
57 
TABLE 9. EFFECT OF ASTEROSAPONIN ON CAT 
Aste ro saponin 
b d !:e-g /kg Blood P ressur e a Time Respiration c Muscle 
0 Initial 100 11. 5 
}.1axir:num 
Effect xi 
H.eturn to 
Nonnal 
0.5 Initial 100 
Max imum 
Effect 70 19 x 
Retu rn to 
Normal 100 33 
1. 0 Initial 100 
Maxim urn 
Effect 50 17 x 
Return to 
Normd)_ 95 44 
2.0 Initial 82 11. 5 
Maxi in um 
Effect 40 20 16. 0 og 
Return to 
No rrnal 82 126 540e 
a 
mm Hg 
b Tirne in seconds from inj ection of drug to maximal effect or for 
return to pre-injection level. 
c Breaths /min. 
d Skeletal muscle response to nerve stin1ulation 
.e Seconds to full recovery 
£ Norrnai TE;spon se to i1erve stimulation 
g Slight dee t·ea se in arnplitude 
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made by the injection of 0 . 5 ml of 0, 9% saline into the rat through 
the venous catheter to evaluate the effect of the injection procedure 
itself. A slight rise in the blood pressur e was noted within 8 seconds. 
It rose fr om the 75 mrn Hg to a level of 82 rnm Hg in 20 seconds and 
the heightened blood pressure las ted for more then 90 seconds. 
The heart rate was 280 beats per :minute during the tirne of activity 
which vvas interpreted as being no t appreciably different from the 
initial value. The ECG did not change. 
The intravenous injection of 1. 0 mg/kg of asterosaponin in the 
rat resulted in a rise in blood pressure from 75 m .m Hg to 90 mm 
Hg in 25 seconds. Heart rate was 300 beats per minute, and the 
shape of the ECG did not change. The data in Table 10 show the 
effects of 2 mg/kg of asterosaponin. There was an initial drop in 
the blood pres sure from 85 to 82 rnm Hg which lasted only eight 
seconds and the pressure returned to about the norrnal level. The 
heart rate just prior to injection and 40 seconds after administration 
was 300 b e-'1 ts per minute, and the ECG pattern was not altered. 
The adrn.inistration of 4. 0 mg/kg asterosaponin (Table 10) was 
the lowest dose in the rat where unequivocal alterations in the rat 
blood p ressure occured. Thr ee to £our seconds after the drug was 
administered there was a drop in blood pressure from an initial 
value 0£ 87 mm Hg to 70 rnm Hg in 18 seconds. The blood pressure 
was back to its normal value 35 seconds afte r drug adrninistration. 
60 
TABLE 10. RAT BLOOD PRESSURE AND ECG REACTIONS 
TO ASTEROSAPONIN I. 
Blood Pres sure (mm Hg) Heart Rate c 
Return to 
Aste ::_o sa p r~~in a foj tia 1 After Normalb Initial After ECG 
0 75 270 +d 
0.5 75 82 90 270 280 + 
l. 0 75 90 270 300 + 
2. 0 85 82 8 300 300 + 
4.0 87 70 35 312 312 + 
8.0 92 75 90 312 312 + 
20.0 82 55 330 300 300 + 
a 
Dos e iv in mg /kg 
b 
Time for :-eturn to pre-drug pressure in seconds 
c 
Beats per minute 
d + = no change in electrocardiograrn recording 
61 
The heart rate was 312 beats per minute before and after drug ad-
ministration and there was no change in the ECG. For the 8. 0 and 
20. 0 mg/kg (Figure 7) doses of asterosaponin the initial blood pres-
sures were 92 and 82 mrn Hg respectively and the initial hearts 
rates were 312 and 300 beats per minute (Table 10). The effect of 
the drug at both doses was basically the same. After the drug was 
administered there was an immediate drop in blood pressure which 
lasted for 25 seconds, while the blood pressure did not completely 
return to its normal value for minutes. The heart rate and the ECG 
were not affected. 
The preceeding results for the effects of the asterosaponin 
were obtained by evaluating only the asterosaponin extracted by 
Les Goldsmith. A similar experiment was performed to compare 
the asterosaponin extracted by Les Goldsmith and the original ex-
tract supplied by Dr. Yuzuru Shimizu. The base line blood pressure 
was 90 mm Hg while the heart rate was 350 beats per minute. The 
effect on blood pressure and ECG of the standard 0. 5 ml saline in-
jection was similar to that seen for the previous expe rirnent. The 
heart rate ren1ained between 350 and 360 beats per 1ninute, while the 
blood pressure rose to a value of 97 mm Hg in 10 seconds. 
Table 11 illustrate s the effects of the inj ection of 4. 0 mg/kg 
of the asterosaponin extracted by Dr. C'. _ .._,n1m1zu. These data show 
that the initial blood pressure was 85 n1m. Hg a nd that the h ea rt 
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TABLE 11. RAT BLOOD PRESSURE AND ECG REACTIONS 
TO ASTEROSAPOI'·JL~ II. 
Blood Pressure (mm Hg) Heart Rate c 
Return to 
Asterosaoonin a Initial After 
. b 
Initial After ECG Normal ___ _,__ 
4. O (S)cl 85 57 480 360 285 drop in 
amplitude 
10. 0 (S) 62 24 60 285 240 no change 
4.0 (S) 85 57 400 360 285 irregular 
10. 0 (S) 107 15 150 340 276 irregular 
20.0 {G) 100 55 390 360 irregular 
40.0 (G) 80 55 120 336 324 irregular 
10. 0 (S) 70 27 85 306 288 drop in 
amplitude 
a 
Dose iv in mg /kg 
b Time for return to pre-drug pressure in seconds 
c . Beats per minute 
d S rep re sen ts sample isolated by Shimizu, G repres e nts sample 
isolated by Goldsmith 
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rate was 360 beats per minute. Four seconds after the aste ro saponin 
administration a reduction in the blood pressure began. Approximate-
ly 60 seconds aite r injection the lo\vest blood pres sure was reached, 
a value of 57 mm Hg, which lasted for about five minutes. The 
blood pressure did not return to normal £or m .ore then eight minutes. 
During these eight minutes the amplitude of the QRS complex of the 
ECG was dee reased and the beats per minute decreased from 360 
to a low of 285 beats per rninute. Several replications were made 
for the rat receiving 10 mg/kg 0£ asterosaponin (Table 11). The 
first 10 mg/kg injection was of Dr. Shimizu' s extract. The heart 
rate at the initiation 0£ the experiment was 285 beats per rninute, 
the blood pressure was 62 mm Hg, and the ECG was normal. Three 
seconds after drug administration the blood pressure started to drop; 
23 seconds aite r injection the pressure hit its lowest level of 24 
mm Hg and the heart rate declined to 240 beats per minute. The 
effect only lasted one minute, and the rate and pressure returned to 
the initial levels. Similar alterations were seen following the ad-
ministration of another 10 mg/kg dose (Figure 8). The blood pres-
sure before the inj e ction was 107 mm Hg and the heart rate was 
340 beats p e r minute, with a normal ECG. After the inj ection the 
pressure plummeted to 15 mn1 Hg in less than 25 seconds, ren1ain ed 
at that level for two rn.inutes and then returr.ied to the 100 mn1 Hg 
level after another 30 seconds. During this time the ECG became 
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irregular; the amplitude increased and the form of the pattern chang-
ed into many strange and uninterpretable shapes. The heart rate 
dropped from the 340 to 276 beats per minute. Figure 9 is the re-
cording of the effect of 20 mg/kg of the Les Goldsmith asterosaponin 
which was ad1ninistered following the second injection and affect 
of the 10 mg/kg 2.sterosaponin of Shirnizu. The blood pressure prior 
to injection was 100 n1m Hg, aDd the heart rate was 340 beats per 
Seven seconds after the intravenous adrn.inistration of the 
asterosaponin, the blood pressure began to drop and 25 seconds 
after the injection the pressure st2.bilized at 55 mm Hg and remained 
at 55 mm Hg for inore then 3 minutes when the next dose of astero--
saponin was administered. Two minutes after the injection the blood 
pressur e was still depressed (75 mm Hg). The ECG had obvious 
disturbances in its pattern, and the heart rate was depressed. 
K. Aster osaponin and the Dog Blood Pressure and Heart Rate 
Intravenous asterosaponin injections at various dosages were 
evaluate d in the dog. These data (Table 12) show that the dog was 
sensitive to asterosaponin at a dose of 2. 0 mg/kg and that the dog 
responded in the characteristic manner to the asterosaponin, i.e., 
followin g the asterosaponin injection a drop in blood pressure was 
seen which was only transient, and the response was dose depend e nt. 
The drop 1n blood pressure was accompanied by an increase in pulse 
pressure at all dosage l eve ls (Figure 10). The increase rn pulse 

67 
C) 
C) UJ 
rl ~ 
::::> 
(/) 
(/) 
UJ 
u ~ 
UJ a.. 
(/) 
Q 
UJ 0 
l9 ~ 0 
u ....... _J 
UJ I- CQ 
TABLE 12. EFFECTS OF ASTEROSAPONIN ON BLOOD PRESSURE 
AND HEART RATE IN THE DOG 
Blood Pres sure 
b 
Pulse 
Prenaration Treatment Dos e a Before After Pressure c ti.S/ADd 
_,__._ 
160 155 60 
l Aste rosaponin 2. 0 - - - 5/22 100 78 77 
180 162 90 
18/20 1 Asterosaponin 3.0 90 70 92 
175 175 60 
0 /10 2 Aste rosaponin 4.0 - - -115 105 70 
18 5 160 65 
25/32 2 Astero sap onin 10. 0 - - -120 88 72 
a 
Dose iv in mg/kg 
b 
mm Hg: Sys to lic/Diastolic 
c 
Pulse pre ssure b efo r e /Pulse pressur e after 
d 
Change in systolic pre ssure/Change in diastolic pressure 
e 
Beats per minute 
Heart Ratee 
Before A fte r 
182 192 
192 200 
225 232 
216 224 
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pressure was due to a disproportionate drop in the diastolic com-
pared to the systolic pre ssure, the diastolic pressure always de-
creased more then the systolic. The heart rate of the dog was in-
creased slightly hy asterosaponin injection at all dosage levels. 
L. Vagal Influence on the Response of Rat Blood Pressur e and 
Heart Rate to Asterosaponin 
Vagal influence was not influential in the creation of the tran-
sient hypotension exhibited by rats following astero saponin admini-
stration as indicate d by experiments performed on atropinized and 
vagotomized rats. Th e results (Table 13) indicate that asterosap-
onin at a dose of 5 mg/kg was capable of reducing the blood pressure 
in rats who had been previously treated with atropine at a sufficient 
level, 0. 5 mg/kg to. suppress any vagal activity. The results also 
show that the a ste rosaponin was capable of producing its effect when 
both vagi we re s eve red. 
M. Hista1nine Releasing Properties of Asterosaponin in the Rat 
The possibility that the as te rosaponin was reacting through 
histamine release was investigated. The data in Table 14 show that 
when the antihistamine diphenhydramine wa s administered to a level 
when exogenously administered h istamine no longe r produced its 
hypotensive effects, aste rosaponin continued to exhibit its hypoten-
sive action. Histamine when injected at 0. 5 mg/kg created a direct 
hypotension. Jn this experi1nent a drop in pressure frorn 100 to SS 
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TABLE 13. RAT BLOOD PRESSURE AND HEART RATE; 
VAGAL INFLUENCE IN THE ACTION OF ASTEROSAPONIN 
Blood Pressureb Heart Rate c 
Treatinent Dose a Initial After Initial After 
Asterosaponin 25. 0 90 45 276 270 
Left Vagus ~ d 
75 70-90 300 Sti1nulation 
Right Vagus 
Stimulation d 100 7 5-115 316 
Atropine 0.5 75 60--75 402 414 
Left Vagus 
Stimulation 75 75 414 390 
Right Vagus 
Stimulation 75 75 390 390 
Asterosaponin 5.0 80 55 414 396 
Cut Vagi 
Asterosaponin 5. 0 77 55 384 396 
a Dose iv in mg/kg 
b 
inm Hg 
c 
Beats per in1nute 
d 
Vagal stimula tio n was 0. 01 volt s , 1. 0 Hz for 5 seconds 
TABLE 14. HISTAMINE RELEASING PROPERTIES OF 
A.STE ROSAPONIN IN THE RAT 
Treatment 
Diphenhyd ra1nine 10. 0 
Histamine 0.5 
Diphenhydramine 10. 0 
Histamine o. 5 
Diphenhydramine 10. 0 
Asterosaponin 15. 0 
a Dose iv in mg/kg 
b 
mm Hg 
Initial 
Blood Pres sur eb 
After 
6c 4 7 100------60------102------75 
100 55 
105--~---70--~---100-1~---60 
60 60 
75--~---50--~--- 75_12 ___ 40 
40 5 
c Time in seconds until next extreme pressure was recorded 
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mm Hg was produced. However, when the histamine was admin-
iste red to the diphenhyd ramine pretreated rat the blood pressure 
did not drop. On the other hand when 15 rng/kg of a ste ro saponin 
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was administered to the same rat that had received the same anti--
histamine pretreatment , the asterosaponin (15 mg/kg) did produce 
the characteristic transient hypotension decreasing the al ready 
lowered blo oci pressure of 40 mm Hg down to 5 mm Hg. 
N. _A_~-~ Blocking_o r Beta Stimu~ating Properties of Aste rosap-
onin in the Rat 
Asterosaponin produces a hypotensive effect when the alpha 
receptors are bloc ked and when the beta receptors are blocked as 
is shown in Table 15. A rat was prepared for the usual blood pres-
sure, ECG evaluation including the venous catheter iza tion. Phen-
oxybenzamine was then administered through the venous catheter 
in doses of 0. 4 mg/kg until sufficient drug was present so that fur-
ther doses no longer lowered blood pressure. It was then consider-
ed that alpha receptor activity was blocked. Asterosaponin inject-
ed at 15 mg/kg produced its transient hypotensive effect dropping 
the already lowered blood pressure from 48 to 30 mm Hg. 
In another rat the possible beta stimulating effect of asterosap-
onin was evaluated (Table 15). When the rat was pr etreated with 
propranolol to the point where excess propranolol was present in 
the animal and b eta receptor activity was blocked, asterosaponin 
TABLE 15. ALPHA BLOCKING AND BETA 
S'T.IMULA TING EFFECTS OF ASTEROSAPONIN 
Blood Pressure b 
Treatment Dose a Initial After 
Phenoxybenz.J.mine 0.4 52c 48 
Phenoxybenz arnine 0.4 48 48 
Asteros2.ponin 15. 0 48 30 
Propranolol 0.9 78 70-75 
Aste ro saponin 15. 0 70 25 
a 
Dose iv in mg /kg 
b 
mm Hg 
c Anirnal had already received phenoxybenz amine to lower the 
blood pres sure to this level 
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was intravenously administered at 15 mg/kg. 'The asterosaponin 
produced a hypotensi ve effect, dropping the blood pres sure from 
70 to 25 mm Hg. 
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0. The Direct Effect of Asterosaponin on the Vasculature and the 
Beta Stimulating Effect of A sterosaponin in the Rat - - The 
Rat Hind Leg Perfusion 
The pas sibility of the a ste rosaponin producing its hypotensive 
response through some centrally mediated mechanism was evaluated 
with the first rat hind leg perfusion preparation. The preparation 
also evaluated the ability of the aste rosaponin to produce hypotension 
via direct action on the vasculature. The data from Table 16 show 
that the asterosaponin at a dose of 6. 25 mg/kg was capable of di-
lating the blood vessels of the rat hind leg upon inj e ctior.. and thus 
increasing the flow of perfusate through that vascular system. 
Spinal cord transection at the cervical level did not inhibit the vessel 
dilating properties of the asterosaponin. 
The data presented in Table 17 were from a hind leg perfusion 
preparation that evaluated the reliability of the preparation, the 
direct effect of asterosaponin on the vasculature, and the beta stim-
ulating effect of the drug. The injection of 4 pg of epinephrine, 
a predominately alpha stimulant caused a constriction of the vas-
culature reflecte d by a drop in the rate of perfusat e flow. Isoprc-
terenol (0. l mg iv) a predominate ly beta agonist, caused an increase 
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TABLE 16. EFFECTS OF ASTEROSAPONIN ON THE 
PERFUSED RAT HIND LIMB I. 
Percent of 
T reatrnent Dose a .qrop s /Minute Control 
Control 38 
Asterosaponin 6.25 52 136 
Transection of spinal cord 40 
Asterosaponin 6.25 56 140 
a . 
ing/kg 
..:.'.. 
1 
.,,, 
-:!< 
:/~ ;..,.: 
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TABLE 17. EFFECTS OF ASTEROSAPONIN ON THE 
PERFUSED RAT HIND LIMB II. 
Amount Percent of Control 
Treatment Injected Droes a Rate of D roEs /Minute 
None 167 
Locke-Ringer l ml 188 100 
Epinephrine 4 ug 108 57 
Locke-Ringer l ml 160 100 
Isoprote renal 0. 1 mg 184 115 
None 180 100 
Propranolol 0. l 1ng 136 75 
None 172 100 
Asterosaponin 15 mg 192 111 
Locke-Ringer 1 rnl 180 100 
Aste ro saponin 30 mg 216 120 
None 168 100 
Propranolol 0. 1 rr1g 152 90 
Isoprote renal 0 .1 mg 
None 152 100 
Propranolol 0.1 mg 
216 142 Asterosaponin 30 mg 
a Drops per minute of perfusate passing through leg. 
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in the flow of pe rfusate while the injection of l ml of perfusate so-
lution had no effect on the flow. Asterosaponin when injected at 
15 or 30 mg iv dos e s into the preparation caused a substantial in-
crease in the rate of p e rfusate flow. The beta stimulating proper-
ties of the asterosaponin were evaluated with a two-fold experiment. 
The preparation was pretreated with propanolol (0. 1 mg iv) a bet2. 
blocker, and then injected with isoproterenol (0. 1 mg}. The result 
of the combination was a slight lowering of the flow of perfusate. 
The animal was again pretreated with propranolol and then treated 
with asterosaponin (30. 0 mg}. This time the flow of perfusate was 
increased in response to the drug treatrn.ent indicating that beta 
blockade failed to alter asterosaponin effect. 
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V. DISCUSSION 
A. Properties Reported in the Literature 
The evaluation of the pharmacological properties possessed 
by the asterosaponin frcm Asterias forbesi was initiated by employ-
ing techniques that would test the compound for pharmacological 
activities that had been demonstrated by other asterosaponins. 
Why starfish contain complex asterosaponin corripounds has been 
considered from the tin1e that the first asterosaponins were extract-
ed (Yasumoto et al., 1964). T he originaL researchers who worked 
with the asterosaponins considered the possibility that the astero-
saponins could be compounds used by the starfish to facilitate food 
procur e ment via some toxic properties directed toward the starfish 1 s 
prey, supposedly acting primarily on the adductor muscles of the 
bivalves on which the starfish often feed (Aldrich, 1957; Nichols, 
1964). Some investigators even thought that if the compound was 
toxic to starfish prey then it was possible that the prey species rnay 
be sensitive to the compound and react to it through some type of 
avoidance response (Pratt and Campbell, 1956). This avoidance 
response reaction w as demonstrated for starfish extracts by Fange 
(1963), Feder and Lasker (1964), and Mackie et al. (1968). 
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The work of Friess et al. (1968) and Friess (1970) demonstrat-
ed that asterosaponin compounds from starfish did react with chol-
inergic systems . His experiments showed that some asterosaponins 
could inhibit the response to stimulation of the cholinergic rat phrenic 
nerve-diaphram preparation. It was expected then that the astero-
saponin from Asterias forbesi might possess some type of reaction 
on cholinergic systems. The clam heart bioassay (Florey, 1966) 
was used to eva mate the cholinergic properties of the asterosaponin. 
The heart of Mercenaria mercenaria was used in these experiments 
to identify any toxic action by the asterosaponin that would give 
the starfish any advantage in the predator--prey relationship. The 
data showed that the assay preparation was very sensitive to acetyl-
choline, reacting to concentrations as low as 5. 5 x l0- 13 M. How-
ever, the asterosaponin had no cholinergic activity for the dose range 
-18 - 7 I of 1. 5 x 10 to l. 5 x 10 g ml and that there were no abnormal 
responses of the heart to the asterosaponin. These data support 
the contention that this asterosaponin from Asterias forb es i does 
not offe r the starfish aid in opening the elam through an action on 
the heart. Other experiments, discussed below, varify that the 
asterosaponin had n0 cholinergic a ctivity. 
The investigation of th e toxicity of the aste rosaponin to clam 
tissues or the response oi mollusk ti ssues to the asterosaponin 
was continue d with an investigab.on of the effect of the asterosaponin 
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on the whole clam using experiments modeled after those of Lavoie 
(1956) and Yasumoto et al. (1964) where holes were drilled into bi-
valve shells and the compound injected into the mantle cavity. The 
data from these experiments show that the asterosaponin did not 
cause the clam to open and that the compound was not toxic to clams, 
even at the high concentrations administered. These results corres -
pond with the work of Burnett (1955, 1960) who showed that Asterias 
forbesi possess sufficient strength to open the bivalve without the 
use of a toxin. 
The possibility remained that even if the asterosaponin was 
not toxic to the cla1n that prey species could be sensitive to the 
compound and initiate an avoidance response to its pressence. 
The experiments of Mackie et al. (1968) were used as a rnodel for 
the experiments performed in this research to test this possibility. 
The data from Table 4 show that the asterosaponin did not initiate 
an avoidance response by Littorina littorea. 
One of the important pharmacological properties reported for 
the asterosaponins is their blood cell lysing capability (Rio ~al. , 
1963, 1965; Yasumoto et al. , 1964; Owellen ~t al. , 197 3 ). The work 
of Rio et al. (1965) is interesting in that they examined asterosap-
onins from five differ e nt species of starfish, one of which was deriv-
ed from Asterias forbesi, but is not b e lieved to be the same com-
pound that was us ed in this investigation. Rio reported h e molytic 
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activity for four of the starfish species used but not for the astero-
saponin from Asterias forbesi. The results show that the astero-
saponin from Asterias forbesJ. used in this investigation was incap-
able of lysing either erythrocytes or leukocytes. 
The aste rosaponin was moderately toxic to mice. When var-
ious doses of asterosaponin were intraperitoneally injected into 
mice the asterosaponin, was shown to produce 100 percent lethality 
-wii:h a dose of 200 mg/kg. These results show that the asterosap-
onin certainly had some pharmacological activity, even though it 
had not demonstrated avoidance response activity, clam toxicity, 
or hemolytic action. 
B. Activities of Asterosaponin not Previously Reported 
The pharrnacological testing of the asterosaponin proceeded 
into an investigation of the compound for activities not previously 
reported to be present in asterosaponins. The method of Koster 
(1959) was used to evaluate the asterosaponin for analgesic activity. 
The asterosaponin did, dose dependently, reduce the number of 
writhes exhibited by a group of mice that had received an intra-
peritoneal injection of dilute acetic acid. The presence of analgesic 
properties on the part of a drug is subjective by definition, and thus 
is difficult to confirm, but when a 25 mg/kg dose of asterosaponin 
caused a reduction in the expression of irritation by 99 percent 
it can at least b e said that there is a strong possibility that the 
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asterosaponin ·is an analgesic. There is no reference to analgesic 
properties being exhibited or tested for by any of the other astero-
saponins reviewed in the literature. 
The initial test used to evaluate the anti-inflarnmatory capa-
bilitie s of the aste rosaponin was the in vitro method of Grant et 
al. (1970). The Grant method evaluated the ability of a compound 
to inhibit the heat denaturation of bovine serum albumin. The abil-
ity oi a compound to inhibit the heat denaturation of protein may 
not be a direct indicator of anti-inflammatory activity but compounds 
~hat are anti-inflammatory do exhibit this property (Grant~~·, 
1970; Mizushina and Kobayashi, 1968). 
The data show that the asterosaponin inhibited the denaturation 
of bovine serum albmnin as did phenylbutazone, and that the astero-
saponin and phenylbutazone produced this inhibition of heat denatur-
ation in a log dose response manner. These results indicate that 
the aste rosaponin has potential as an anti-inflammatory agent, and 
further investigation into the anti-inflam1nato ry potentia 1 of the 
, compound seemed desirable. 
Following the positive results obtained for anti-inflarnmatory 
activity for the asterosa.ponin with the bovine serum albumin assay, 
a more stringent in vivo assay was used to evaluate the aste rosaponin. 
The carrageenin induced rat hind paw edema assay of Winter was 
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chosen for this purpose, (Winter et al., 1965) with the volume of 
the paw being measured plethysmographically following the proce -
<lure of Van arman et al. (1965). While it is not clear why anti-
inflammatory agents inhibit the denaturation of protein it is equally 
obscure as to why the injection of carrageenin causes such marked 
inflammation. The carrageenin, which is a high molecular weight 
polysacchari d,~ is derived from either of two algae Chondrus crispus 
or 92:.g~rtina st_!::llata, and has been hypothesized to create inflamma-
tion by many different means. Crunkhorn and Meacock (1971) and 
DiRosa (1972) concluded that it may be due to: irritant properties, 
the release of histamine, 5-hydroxytryptamine, or bradykinin, 
prostaglandins, and even reaction with the blood complement system_ 
as a 11 trigger 11 for non-immune inflammation. Nevertheless, the 
rat paw edema assay is a universally accepted method for the in 
vivo evaluation of anti-inflammatory activity. The assay results 
showed (Tal>le .6) that both a stero saponin and phenylbutazone re strict-
ed the edema formed as a result of carrageenin injection. Phenyl -
butazone (90 mg/kg) restricted the edema by 5 2 percent and astero-
saponin (7 5 mg /kg) restricted the edema by 53 percent. The pos ·-
itive results of the bovine serum albmnin assay and these results 
that show that the asterosaponin restricted the edema in rats to the 
same extent as phenylbutazone , establishes the asterosaponin from 
l 
Asterias forbesi as an anti-in£la1nmatory agent. The combination 
85 
of anti-inflammatory and analgesic activity is advantageous for 
possible drug compounds. Since the asterosaponin exhibits these 
properties it is an excellent candidate for further evaluation, how-
ever the potent hypotensive properties of the compound could restrict 
the use of the asterosaponin to certain specific situations. Never-
theless the analgesic and anti-inflammatory properties of the astero-
saponin are deserving of more investigation. 
C.- Cardiovascular Effects 
The effect of asterosaponins on the mammalian cardiovascular 
3ystem had not been investigated previously and the effects of the 
asterosaponin on respiration, skeletal muscle contraction, and 
autonomic nervous system functioning had only been studied using 
the isolated rat phrenic nerve-diaphram preparation (Friess et al., 
1968; Friess, 1970). The results obtained by Friess showed that 
saponin extracts from both sea cucumbers and starfish inhibited 
the response of the neuronally stimulated rat phrenic nerve-diaphram 
preparation. The rat phrenic nerve-diaphram preparation is chol-
inergic in nature and the destruction of its excitability by astero-
saponin suggests anti-cholinergic activity. The work of Friess in-
dicated that asterosaponins possess properties that are manifested 
in mam1nalian systems, in contrast to the early work that was usual-
ly restricted to investigating the effects of starfish extracts on lower 
species. These studies showed that the asterosaponin did indeed 
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exhibit true pharmacologic activity which could not be explained 
by alluding to sirnple chemoreceptor sensitivity as could be done 
Io r avoidance response reactions, or shell gaping activity. The 
property demonstrated by Friess however was a type of anti-chol-
ine rgic activity which is not demonstrated by the asterosaponin 
from Asterias forbesi, as illustrated below. 
The intravenous injection of the aste rosaponin from Aste rias 
forbesi. caused significant results . In the cat dosages of 0. 5 and 
1. 0 mg/kg (Table 9) of the asterosaponin caused a sudden, evanes-
cent drop in blood pressure with little or no effect on respiration , 
the contraction of the nictitating m e mbrane or skeletal muscle. 
The 2. 0 r.ng/kg iv injection of asterosaponin created an even greater 
drop in bloo d pressure lasting much longer and caused an increase 
in the respiratory rate along with a sli g ht decrease in the amplitude 
oi the contractions of the skeletal muscle. Obviously the astero-
saponin from Ast~rias forbesi was not inhibiting the activity of th e 
phrenic nerve of the cat, as the respiratory rate rose and certainly 
the compound was not exerting any type of anticholinergic activity 
as the cholin ergic fibers of the pe ro neal nerve innervating the tib-
ialis ante rior muscle were func.tioning almost normally. The lack 
of anticho linergic activity by the asterosaponin was also shown by 
the dr op in blood p1·essure, if the compound we re exerting anti-
cholinergic activity the blood pressure would be expected to rise, 
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as a result of the loss of parasympathetic control. The compound 
did not appear to have any effect on the ganglia or the functioning 
of adrenergic nerves, as the responses to preganglionic stimulation 
of the nictitating membrane were normal. The hypotensive activity 
of the asterosaponin was investigated in rats and dogs after these 
effects were seen on the cat. The experiments performed on rats 
(Tables 10 and 11) and dogs (Table 12) show that the asterosaponin 
could cause a transient hypotensive effect at low dosage, although 
not as low as in the cat and that the extent of the hypotension and 
the time which it lasted were both dose dependent. 
No effect on heart rate or ECG in response to this asterosap-
onin injection were seen. These data correspond with the lack of 
activity the compound had demonstrated on the autonomic nervous 
system of the cat and suggested that the hypoten sive activity seen 
with the asterosaponin was not due to a depressor activity on the 
heart. In one rat the asterosaponin did appear to cause a depression 
in the heart rate. However, it is not believed that this was a direct 
effect of the drug, but rather a product of a unique rat preparation, 
or some type of a reflex. This is believed because injections of 
both the Goldsmith and Shimizu extracted asterosaponin into this 
rat precipitated ECG irr egula rities and a drop in heart rate. On 
all other occasions the asterosaponin did not effect the ECG or the 
heart rate of the rat. The iv inj ection of asterosaponin i nto the 
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dog created dose dependent hypotension and an increase in the heart 
rate, probably through a compensatory mechanism. The hypotension 
produced in the dog was unique in that the pulse pressure increased 
as a result of asterosaponin administration. Experiments performed 
by Lederis and Medakovic (1974) with extracts of teleost fish pro-
duced similar results in the rat. In the experiments by Lederis and 
Medakovic pulse pressure was increased following the administration 
of drug and the increase was due to a more extensive drop in dias -
tolic pressure then in systolic pressure. They concluded that this 
j_ndicated dilation of resistanc~ vessels. Siinilar results were ob-
tained with the dog preparation subjected to asterosaponin injections. 
At all dosages of asterosaponin the pulse pressure increased due 
to a greater depression in diastolic rather than systolic pressure, 
implicating some type of vasodilai:ion as being produced by the 
asterosaponin. Lederis and Medakovic also observed a reflex m-
crease in heart rate due to the hypotension caused by the teleost 
extract. The results of the dog heart rate and blood pressure ex-
periments indicated that the asterosaponin rn.ight have created its 
hypotensive effect via a direct action on the vasculature . The pro-
duction of hypot e nsion by the asterosaponin by working directly on 
the vasculature would also explain the effects of the asterosaponin 
on the respirato ry rate of the cat. Schoop e t~· (1957) demonstrate d 
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that the hypotension produced by nitroglycerine caused a reflex 
hyperpnea in the rat. Thus if the asterosaponin was causing dir e ct 
vasodilation the respiratory stimuiation might be explained. 
The transient hypotensive effect of asterosaponin injection was 
further investigated as to the mechanism of its action. The expe r -
iments performed on the cat and dogs had not sufficiently establish-
ed how the asterosaponin was creating its effe.:::t so fur·ther exper-
im.ents \Vere performed on rats whose blood pressure and ECG were 
monitored, under a variety of conditions. 
The possibility of the asterosaponin creating hypotension through 
vagal stimulation was investigated by testing the effect oi asterosap-. 
onin on atropinized and vagotornized rats (Table 13). These results 
show that the asterosaponin continued to exhibit its hypotensive 
effect even when the vagus nerves were sever e d. These results in 
ccnjunction with the results from the cat experi1nent that showed no 
cholinergic activity, and the negative results gained with the cla1n 
heart assay for cholinergic activity, discount the possibility 0£ the 
asterosaponin from Asteria_::; forbesi acting through vagal stimulation. 
The asterosaponin was examined £or histamine releasing prop-
erties in rats (Table 14). These data shovv· that antihistamine pre-
treatment did not interfere with a ste ro saponjn-induced hypo tension.. 
These resul ts correspond with the anti-inflamrn.atory activity of 
the asterosaponin so that it can be concluded that the hypotensive 
action of the asterosaponin is not due to endogenous histamine 
release. 
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The data from the cat and dog blood pres sure experiments 
indicate that the aste rosaponin worked directly on the vasculature. 
The lack of effect exhibited by the asterosaponin on the cat nictitat-
ing rn.ernbrane preparation indicated that the drug was not acting 
through the autonomic nervous system. The possibility that the 
hypotensive action was due to alpha adrenergic blockade or beta 
2drenergic stimulation was further evaluated with the rat blood pres-
sure and hind leg exp eriments . The experiments performed on rat 
Blood pressure and ECG (Table 15) established that the asterosap-· 
onin was fully capable of eliciting its characteristic hypotensive 
response when the alpha or beta receptors were blocked. These 
results thus add strength to the contention that the asterosaponin 
is not an alpha blocker or a beta stimulant. 
The rat hind l eg perfusion preparation supplied much needed 
information on the mechanism of action of the asterosaponin. The 
first hind leg perfusiun preparation (Table 16) established that the 
asterosapoGin was not acting through any centrally rnedjated process 
by showjng that t~e: asterosaponin continued to be effective as a 
hypotensive agent even after cerv ical tr-an section. Th e second 
preparation (Table 17) showed that the asterosaponin was not acting 
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through beta stimulation, and together with the data obtained from 
the rat alpha blockade and beta stimulation experiments produced 
enough evidence to establish that the aste rosaponin was not acting 
through any adrene rgic mechanism. The. data obtained frorn the 
hind leg perfusion experiments, along with all the other data pro-
duced i.D the inv e stigation of the aste rosaponin' s activity establish 
that the astero saponin from Asterias forbesi created its hypotensive 
effects thrcugh direct action on the vasculature. 
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VI. SUMMARY AND CONCLUSIONS 
1. The asterosaponin extracted from the Atlantic starfish Asterias 
forbesi exhibited no cholinergic activity towards the Mercenaria 
mercenaria heart bioassay for acetylcholine at concentrations 
-18 I -18 -7 I ranging from 1. 5 x 10 g ml (1. 0 x 10 M) to 1. 5 x 10 g ml 
-7 (l. 0 x 10 M). 
2. The aste rosaponin produced no observable e££ects on the whole 
clam Merc enaria rnercenaria when a dose of l. 5 x 10- 4 g/ml 
was injected into the mantle cavity. 
3. No blood ceil lysing activity was exhibited by the asterosaponin 
when tested from O. 3 mg /ml to 10. 0 mg /ml. 
4. The asterosaponin produced no autotomy in Asterias forbesi 
at a concentration of l. 5 x l0- 4 g/ml when injected into the 
peritoneal cavity. 
5. No escape response was elicited in Littorina littorea by astero-
saponin when 1 ml of 1. 5 x l0- 5g/ml was injected near the head 
of the snail that was in a dish of sea water. These results 
along with the results of the clam heart bioassay, and the whole 
clam assay indicate that the asterosaponin is probably not used 
by the starfish to facilitate prey procurement. 
6. The asterosaponin inhibited the heat denaturation of l percent 
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bovine serum albumin by 89 percent when added to the incubation 
medium at a concentration of 1000 pg/ml. This inhibition of 
denaturation was dose dependent and suggestive of possible 
anti-inflammatory activity. 
7. The asterosaponin at 75 m.g/kg inhibited rat paw edema formation 
due to subplanter injection of carrageenin by 53 percent. The 
results of the i~ vitro_ bovine serum albumin assay and those 
of the in ;:i.Yo carrageenin induced hind paw edema assay es-
tablish the asterosaponin as an anti-inflammatory agent. 
3. The LD50 of the asterosaponin to mice was between 100 and 
200 mg/kg. 
9. The blood pressure of the c at dropped in response to 0. 5 mg/kg 
of the intravenously administered asterosaponin. The respi-
ratory rate rose and the blood pressure fell in response to 
2. 0 m .g /kg of the asterosaponin, but there wa s no effect en the 
preganglion ic stimulation of the nictitating membrane and littl e 
effect on the neuronal stimulation of ske letal muscle at the 
2. 0 mg/kg l evel. 
10. Transient, dose dependent hypotension was produced in rats 
administered asterosaponin (4. 0 to 20. 0 mg/kg). The heart 
rate and ECG were not appreciably directly affected by the 
compound. 
~ ~·· ................ _______ , _ __,._ __ . 
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11. The iv administration of asterosaponin (2. 0 to 10. 0 mg/kg) 
caused transient hypotension in the dog. This hypotension was 
indicative of va sodilation as the pulse pressure rose because 
of a greater drop in diastolic rather than systolic pressure. 
Heart rate rose following asterosaponin induced hypotension 
probably as a compensatory mechanism. 
12. In the rat, the asterosaponin (5. 0 mg/kg) caused hypotension 
even afte1· tre yagus nerves were severed. This along with the 
lack of cholinergic activity exhibited by the clam heart bioassay 
for acetylcholine, the lack of effect the asterosaponin exhibited 
on the neuronaily stinrnlated skeletal muscle of the cat, and the 
increase in respiratory rate of the cat established that the 
asterosaponin was not causing hypotension through vagal stim-
ulation or cholinergic activity. 
13. The asterosaponin (15 mg/kg) continued to exhibit its character-
istic evanescent hypotension following antihistamine (diphen-
hydramine 10 mg /kg) pretreatment. This indicated that the 
asterosaponin did not produce hypotension through endogenous 
histamine r e lease. These conclusions were supported by the 
anti-inilarnmatory properties oi the asterosaponin . 
14. The aste r osaponin's (15 mg/kg) hypotensive properties rn the 
rat were not stopped by alpha adrenergic blockade by phenoxy-
b enzan1ine (0. 4 mg/kg). These results along with the lack of 
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activity the asterosaponin had on the nictitating membrane of 
the cat established that the asterosaponin was not causing hypo-
tension th.rough alpha blockade. 
15. When the aste rosaponi n (15 mg/kg) was injected iv into the rats 
pretreated with the beta adrenergic blocking agent propranolo l 
(0. 9 mg/kg), the hypotensive activity was still present, indi-
eating thac the as te rosaponin was not a beta stimulator. The 
absence of beta-stimulating properties by the asterosaponin 
was further established by the results of the rat hind leg per-
fusion experiments, where 30 mg of asterosaponin was effect-
ive in creating hypotension after established beta blockade. 
16. The fa.ct th.at the asterosaponin was not causing hypotension 
through any cenLally mediat e d process was established when 
cervical t r ansection of the hind leg perfusion preparation fail-
ed to diminish the asterosaponin (6. 25 mg) induced vasodilation. 
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